Ken Griffin Milestone Pharmaceuticals Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 200 shares of MIST stock, worth $360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 15,900
98.74%
Holding current value
$360
Previous $20,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MIST
# of Institutions
45Shares Held
28.7MCall Options Held
200Put Options Held
0-
Black Rock Inc. New York, NY4.97MShares$8.95 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$5.86 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$5 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$4.79 Million1.79% of portfolio
-
Orbimed Advisors LLC San Diego, CA2MShares$3.6 Million0.07% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $54M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...